The estimated Net Worth of Pamela J. Craig is at least 6.74 百万$ dollars as of 15 May 2019. Ms. Craig owns over 8,381 units of Merck & Co Inc stock worth over 5,860,419$ and over the last 13 years she sold MRK stock worth over 534,090$. In addition, she makes 348,500$ as Independent Director at Merck & Co Inc.
Sign up
Ms. Craig MRK stock SEC Form 4 insiders trading
Pamela has made over 22 trades of the Merck & Co Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently she exercised 8,381 units of MRK stock worth 961,385$ on 15 May 2019.
The largest trade she's ever made was exercising 26,333 units of Merck & Co Inc stock on 9 February 2018 worth over 3,020,658$. On average, Pamela trades about 735 units every 25 days since 2011. As of 15 May 2019 she still owns at least 51,089 units of Merck & Co Inc stock.
You can see the complete history of Ms. Craig stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Pamela Craig biography
Pamela J. Craig serves as Independent Directorof the Company. Ms. Craig has extensive finance, management, operational, technology and international business expertise, including her history of accomplishment and executive ability as Chief Financial Officer of Accenture plc. In addition, her directorships at other public companies, including her service as a member of the Audit and Finance Committees of 3M Company and as a member of the Compensation Committee of Progressive Insurance, provide her with valuable experience on governance issues facing public companies. Accenture plc, global management consulting, technology services and outsourcing company, Chief Financial Officer (2006-2013) Senior Vice President, Finance (2004-2006) Group Director, Business Operations and Services (2003-2004) Managing Partner, Global Business Operations (2001-2003) 3M Company Inc. (since 2019) Progressive Insurance (since 2018) ?Akamai Technologies, Inc. (2011-2019)?Wal-Mart Stores, Inc. (2013-2017).
What is the salary of Pamela Craig?
As the Independent Director of Merck & Co Inc, the total compensation of Pamela Craig at Merck & Co Inc is 348,500$. There are 11 executives at Merck & Co Inc getting paid more, with Kenneth Frazier having the highest compensation of 27,648,500$.
How old is Pamela Craig?
Pamela Craig is 63, she's been the Independent Director of Merck & Co Inc since 2015. There are 10 older and 17 younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
What's Pamela Craig's mailing address?
Pamela's mailing address filed with the SEC is 6300 WILSON MILLS ROAD, , MAYFIELD VILLAGE, OH, 44143.
Insiders trading at Merck & Co Inc
Over the last 15 years, insiders at Merck & Co Inc have traded over 138,980,380$ worth of Merck & Co Inc stock and bought 48,209 units worth 1,563,736$ . The most active insiders traders include Wendell P Weeks、Kenneth C Frazier、Douglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of 5,050,222$. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth 4,250,995$.
What does Merck & Co Inc do?
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
What does Merck & Co Inc's logo look like?
Complete history of Ms. Craig stock trades at Akamai Technologies Inc、3M Co、Accenture plc、Corning、Merck & Co Inc、Progressive、Vmware、Walmart Inc
Merck & Co Inc executives and stock owners
Merck & Co Inc executives and other stock owners filed with the SEC include:
-
Kenneth Frazier,
Chairman of the Board, President, Chief Executive Officer -
Roger Perlmutter,
Executive Vice President, President - Merck Research Laboratories -
Robert Davis,
Executive Vice President, Global Services, Chief Financial Officer -
Sanat Chattopadhyay,
Executive Vice President and President - Merck Manufacturing Division -
Jennifer Zachary,
Executive Vice President, General Counsel, Corporate Secretary -
Kenneth C. Frazier,
Exec. Chairman -
Robert M. Davis,
Pres, CEO & Director -
Jennifer L. Zachary,
Exec. VP, Gen. Counsel & Corp. Sec. -
Sanat Chattopadhyay,
Exec. VP & Pres of Merck Manufacturing Division -
Thomas Cech,
Independent Director -
Leslie Brun,
Lead Independent Director -
Pamela Craig,
Independent Director -
Thomas Glocer,
Independent Director -
Paul Rothman,
Independent Director -
Peter Wendell,
Independent Director -
Inge Thulin,
Independent Director -
Patricia Russo,
Independent Director -
Mary Coe,
Independent Director -
Kathy Warden,
Independent Director -
Christine Seidman,
Independent Director -
Michael Fleming,
Senior Vice President, Chief Ethics and Compliance Officer -
Rita Karachun,
Senior Vice President Finance - Global Controller -
Julie Gerberding,
Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health -
Richard DeLuca,
Executive Vice President, President - Merck Animal Health -
Franklin Clyburn,
Executive Vice President, Chief Commercial Officer -
Michael Nally,
Executive Vice President, Chief Marketing Officer -
Steven Mizell,
Executive Vice President, Chief Human Resources Officer, Human Resources -
Cristal N. Downing,
Exec. VP and Chief Communications & Public Affairs Officer -
Michael W. Fleming,
Sr. VP and Chief Ethics & Compliance Officer -
Peter Dannenbaum,
VP of Investor Relations -
Jennifer Mauer,
VP of Global Communications -
Peter Dannenbaum CFA,
VP of Investor Relations -
David Michael Williams,
Chief Information & Digital Officer -
Caroline Litchfield,
Exec. VP & CFO -
Rochelle B Lazarus,
Director -
Craig B. Thompson,
Director -
Adam H Schechter,
EVP & Pres-Global Human Health -
Adele D Ambrose,
V-P & Chief Com. Officer -
Clark Golestani,
EVP & Chief Info Officer -
John H Noseworthy,
Director -
Wendell P Weeks,
Director -
Michael J Holston,
EVP, Chief Ethics & Compl Ofcr -
Carlos E Represas,
Director -
C Robert Kidder,
Director -
Weir Mirian M Graddick,
Exec. V-P, Human Resources -
Ashley Watson,
SVP Chief Ethics & Com Officer -
Frank Clyburn,
EVP & Pres ? Human Health -
James H Scholefield,
EVP,Chief Info&Digital Officer -
Joseph Romanelli,
President, Human Health Int?l -
Stephen Mayo,
Director -
Dean Y Li,
Executive VP & President, MRL -
David Michael Williams,
EVP,Chief Info&Digital Officer -
William B Jr Harrison,
Director -
Michael Rosenblatt,
Exec V-P & Chief Med Officer -
John Canan,
Senior V-P, Controller -
Stanley F Barshay,
Exec V-P Consumer Health Care -
Willie A Deese,
Exec. V-P and Pres., MMD -
Anne M Tatlock,
Director -
Samuel O Md Thier,
Director -
Mervyn Turner,
Chief Strategy Officer -
Willam N Kelley,
Director -
Richard S Iii Bowles,
Exe V-P & Chief Compl Officer -
Peter S Kim,
Exec. V-P and Pres., MRL -
Thomas E Shenk,
Director -
Bridgette P Heller,
Exe.VP & Pres.Con.Hlth.Care -
Raul E Kohan,
Exe V-P & Pres, Animal Health -
Steven F Goldstone,
Director -
Harry R Jacobson,
Director -
Richard T Clark,
Chairman, President and CEO -
Peter N Kellogg,
Exec. V.P. & C.F.O -
Bruce N Kuhlik,
Exec. V.P. and General Counsel -
Cuong V Do,
EVP & Chief Strategy Officer -
J Chris Scalet,
Exe. VP, Global Services & CIO -
Risa J Lavizzo Mourey,
Director -
Johannes Jacobus Oosthuizen,
President, U.S. Market -
Caroline Litchfield,
EVP & CFO -
Lisa Le Cointe Cephas,
SVP Chief Ethics & Com Officer -
Michael A Klobuchar,
EVP - Chief Strategy Officer -
Arpa Garay,
SVP Human Health Global Mktg. -
Cristal N Downing,
Chief Comm. & Public Afrs Ofcr -
Douglas M Jr Baker,
Director -
Chirfi Guindo,
Chief Marketing Officer -
Dalton Smart,
SVP Fin. - Global Controller -
Betty D Larson,
EVP, Chief HR Officer